SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-16-682053
Filing Date
2016-08-15
Accepted
2016-08-15 17:18:53
Documents
45
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d207833d10q.htm 10-Q 335696
2 EX-10.1 d207833dex101.htm EX-10.1 372894
3 EX-10.2 d207833dex102.htm EX-10.2 109622
4 EX-31.1 d207833dex311.htm EX-31.1 8688
5 EX-31.2 d207833dex312.htm EX-31.2 8137
6 EX-32.1 d207833dex321.htm EX-32.1 4823
7 EX-32.2 d207833dex322.htm EX-32.2 4279
  Complete submission text file 0001193125-16-682053.txt   2507924

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT wve-20160630.xml EX-101.INS 284618
9 XBRL TAXONOMY EXTENSION SCHEMA wve-20160630.xsd EX-101.SCH 25849
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE wve-20160630_cal.xml EX-101.CAL 42402
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE wve-20160630_def.xml EX-101.DEF 98476
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE wve-20160630_lab.xml EX-101.LAB 226962
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE wve-20160630_pre.xml EX-101.PRE 156183
Mailing Address 8 CROSS STREET #10-00 SINGAPORE U0 048424
Business Address 8 CROSS STREET #10-00 SINGAPORE U0 048424 617-206-4830
Wave Life Sciences Ltd. (Filer) CIK: 0001631574 (see all company filings)

IRS No.: 000000000 | State of Incorp.: U0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37627 | Film No.: 161833957
SIC: 2834 Pharmaceutical Preparations